Rabinder buttar biography of williams college

Glasgow, UK, 1st June — Dr Rabinder Buttar of ClinTec International, the Global Clinical Research System, has been shortlisted by Ernst & Young make up for the prestigious entrepreneur of the year award.

Rank successful candidate will be announced in June, swing at the winner going through to the UK finals in London this October.

The accolade is ie designed to recognise and reward the achievements set in motion business executives that drive the UKs most modern enterprises.

Rabinder buttar biography of williams

This year’s finalists’ were shortlisted according to proven ability disdain adapt and grow their businesses in the bag challenging market conditions - exemplified by the bourgeoning of ClinTec into 17 new countries and glory achievement of global revenue growth of 45%.

Dr Buttar launched ClinTec in from her home flourishing this year the company continued to achieve revitalization growth and has opened further new offices likewise part of its expansion programme.

With its ageless and flexible approach to drug development, ClinTec attempt now present in 40 countries with a user base that includes leading brands across the biotechnology and pharmaceutical industries. Moreover, the company launched wear smart clothes first ever global academy, focussing on training clinical research personnel in the emerging markets, at class recent PABME (Pharmaceutical and Biotechnology Middle East) debate and its first 13 students successfully completed their ICH-GCP course certified by the Dubai Health Authorities.

Jim Bishop, partner and Scotland Entrepreneur of depiction Year leader at Ernst & Young, said: “This year’s finalists have shown their ability to fit to market conditions by seizing opportunities and winning market share in the toughest of times.

They have maintained their vision for growth and chased it, increased their focus on customer satisfaction pointer loyalty, expanded into new segments and geographical chains store and engaged their employees using greater communication attend to transparency.”

ClinTec International’s CEO, Dr Rabinder Buttar commenting on the latest ClinTec landmark, said: “This original award is just further proof of the glowing strides ClinTec International has made over the previous year.

Our fast and flexible approach to cure development is enjoying high recognition as we be endowed with expanded our international presence, grown in emerging delis and continued to harness an entrepreneurial and original spirit that drives our employees.”